Summary: Dave Ricks, head of Lilly's Bio-Medicines group, discusses the pharma giant's competitive advantages with Morningstar's Damien Conover.
Summary: Dave Ricks, head of Lilly's Bio-Medicines group, discusses the pharma giant's competitive advantages with Morningstar's Damien Conover.